Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Kriegsmann

Showing results (131-140 of 178) with videos related to

Pageof 18
Sort By:
Cancers|January 12, 2021
Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of VersicanDavid Brunn, Kati Turkowski, Stefan Günther, et al.
Cold Spring Harbor Molecular Case Studies|January 21, 2022
Histological and molecular plasticity of ALK-positive non-small-cell lung cancer under targeted therapy: a case reportMarkus Ball, Petros Christopoulos, Martina Kirchner, et al.
BMC Cancer|May 2, 2021
Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samplesKatharina Kriegsmann, Christiane Zgorzelski, Thomas Muley, et al.
Cancers|October 16, 2024
Germline Polymorphisms Associated with Overall Survival in Lung Adenocarcinoma: Genome-Wide AnalysisFrancesca Minnai, Sara Noci, Martina Esposito, et al.
BMC Cancer|January 17, 2019
Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodiesMark Kriegsmann, Stephanie Roessler, Katharina Kriegsmann, et al.
Cancers|September 23, 2022
Lung Adenocarcinoma Cell Sensitivity to Chemotherapies: A Spotlight on Lipid Droplets and <i>SREBF1</i> GeneAnna Ricarda Gründing, Marc A Schneider, Sarah Richtmann, et al.
Frontiers in Oncology|April 26, 2021
<i>De Novo</i> Versus Secondary Metastatic <i>EGFR</i>-Mutated Non-Small-Cell Lung CancerFarastuk Bozorgmehr, Daniel Kazdal, Inn Chung, et al.
JCO Precision Oncology|September 14, 2020
Frequent Molecular Subtype Switching and Gene Expression Alterations in Lung and Pleural Metastasis From Luminal A-Type Breast CancerMax Klebe, Carlo Fremd, Mark Kriegsmann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2021
A Tuft Cell-Like Signature Is Highly Prevalent in Thymic Squamous Cell Carcinoma and Delineates New Molecular Subsets Among the Major Lung Cancer HistotypesYosuke Yamada, Katja Simon-Keller, Djeda Belharazem-Vitacolonnna, et al.
BMC Cancer|June 2, 2018
Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort studyCina J Nattenmüller, Mark Kriegsmann, Disorn Sookthai, et al.
Pageof 18

Showing results (131-140 of 178) with videos related to

Sort By:
Pageof 18
Cancers|January 12, 2021
Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of VersicanDavid Brunn, Kati Turkowski, Stefan Günther, et al.
Cold Spring Harbor Molecular Case Studies|January 21, 2022
Histological and molecular plasticity of ALK-positive non-small-cell lung cancer under targeted therapy: a case reportMarkus Ball, Petros Christopoulos, Martina Kirchner, et al.
BMC Cancer|May 2, 2021
Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samplesKatharina Kriegsmann, Christiane Zgorzelski, Thomas Muley, et al.
Cancers|October 16, 2024
Germline Polymorphisms Associated with Overall Survival in Lung Adenocarcinoma: Genome-Wide AnalysisFrancesca Minnai, Sara Noci, Martina Esposito, et al.
BMC Cancer|January 17, 2019
Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodiesMark Kriegsmann, Stephanie Roessler, Katharina Kriegsmann, et al.
Cancers|September 23, 2022
Lung Adenocarcinoma Cell Sensitivity to Chemotherapies: A Spotlight on Lipid Droplets and <i>SREBF1</i> GeneAnna Ricarda Gründing, Marc A Schneider, Sarah Richtmann, et al.
Frontiers in Oncology|April 26, 2021
<i>De Novo</i> Versus Secondary Metastatic <i>EGFR</i>-Mutated Non-Small-Cell Lung CancerFarastuk Bozorgmehr, Daniel Kazdal, Inn Chung, et al.
JCO Precision Oncology|September 14, 2020
Frequent Molecular Subtype Switching and Gene Expression Alterations in Lung and Pleural Metastasis From Luminal A-Type Breast CancerMax Klebe, Carlo Fremd, Mark Kriegsmann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2021
A Tuft Cell-Like Signature Is Highly Prevalent in Thymic Squamous Cell Carcinoma and Delineates New Molecular Subsets Among the Major Lung Cancer HistotypesYosuke Yamada, Katja Simon-Keller, Djeda Belharazem-Vitacolonnna, et al.
BMC Cancer|June 2, 2018
Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort studyCina J Nattenmüller, Mark Kriegsmann, Disorn Sookthai, et al.
Pageof 18